What does PHARMACIE CHAUSSEE DE GAND do?

PHARMACIE CHAUSSEE DE GAND is a pharmacy in Sint-Jans-Molenbeek. Private Limited, started on 27 June 2001, 1 establishment.

What is the address of PHARMACIE CHAUSSEE DE GAND?

The registered office of PHARMACIE CHAUSSEE DE GAND is located at Gentsesteenweg 120, 1080 Sint-Jans-Molenbeek.

Is PHARMACIE CHAUSSEE DE GAND still active?

Yes. According to the CBE (18 September 2026) PHARMACIE CHAUSSEE DE GAND is active, legal situation “Normale toestand”, started on 27 June 2001.

Is PHARMACIE CHAUSSEE DE GAND registered on Peppol?

Yes, PHARMACIE CHAUSSEE DE GAND is registered on the Peppol network with ID 0208:0475089865.

What is the enterprise number of PHARMACIE CHAUSSEE DE GAND?

The enterprise number of PHARMACIE CHAUSSEE DE GAND is BE0475089865.

When was PHARMACIE CHAUSSEE DE GAND founded?

PHARMACIE CHAUSSEE DE GAND was founded on 27 June 2001.

Is PHARMACIE CHAUSSEE DE GAND a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 June 2001; 4 annual accounts filed, latest fiscal year 2024.

How much profit did PHARMACIE CHAUSSEE DE GAND make in 2024?

PHARMACIE CHAUSSEE DE GAND recorded a loss after taxes of € 45,938 in financial year 2024.

What is the revenue of PHARMACIE CHAUSSEE DE GAND?

As a small company, PHARMACIE CHAUSSEE DE GAND is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 3,240.

PHARMACIE CHAUSSEE DE GAND (Private Limited)

Dossier PHARMACIE CHAUSSEE DE GAND, printed on 18 September 2026 from databakkes.be/en/0475089865/pharmacie-chaussee-de-gand. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2023 and 2024.

Financials

Financial year 2024

PHARMACIE CHAUSSEE DE GAND from Sint-Jans-Molenbeek, company number BE0475089865, closed financial year 2024 with a result of € -45,938 after tax. For that financial year PHARMACIE CHAUSSEE DE GAND recorded a gross margin of € 3,240 and equity of € 97,902. Compared with financial year 2023, the result moved from € -47,004 to € -45,938. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 27, 2025.

What it is worth Healthy

€ 97,902

▼ 32% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -45,938

▲ 2 % less loss than in 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 58,865

▲ 60% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 79,302.

People and assets in 2024

Wage cost

€ 2,108

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 10,140

▼ 40% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 68,710

▲ 60% vs 2023

€ 32,857 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 81,415

▼ 28% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 21,207

▲ 42% vs 2023

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 72,474 Gross margin 2021: € 72,474 First fiscal year in the series	€ 53,622 Gross margin 2022: € 53,622 ▼ 26% vs 2021 (€ 72,474) Unfavourable step	€ -6,040 Gross margin 2023: € -6,040 ▼ € 59,662 vs 2022 (€ 53,622) Unfavourable step	€ 3,240 Gross margin 2024: € 3,240 ▲ € 9,280 vs 2023 (€ -6,040) Favourable step	▲ € 9,280
Profit after taxes	€ 28,184 Profit after taxes 2021: € 28,184 First fiscal year in the series	€ 6,869 Profit after taxes 2022: € 6,869 ▼ 76% vs 2021 (€ 28,184) Unfavourable step	€ -47,004 Profit after taxes 2023: € -47,004 ▼ € 53,874 vs 2022 (€ 6,869) Unfavourable step	€ -45,938 Profit after taxes 2024: € -45,938 ▲ € 1,066 vs 2023 (€ -47,004) Favourable step	▲ € 1,066
Equity	€ 183,975 Equity 2021: € 183,975 First fiscal year in the series	€ 190,844 Equity 2022: € 190,844 ▲ 4% vs 2021 (€ 183,975) Favourable step	€ 143,840 Equity 2023: € 143,840 ▼ 25% vs 2022 (€ 190,844) Unfavourable step	€ 97,902 Equity 2024: € 97,902 ▼ 32% vs 2023 (€ 143,840) Unfavourable step	▼ 32%
Total debts	€ 198,258 Total debts 2021: € 198,258 First fiscal year in the series	€ 167,093 Total debts 2022: € 167,093 ▼ 16% vs 2021 (€ 198,258) Favourable step	€ 188,984 Total debts 2023: € 188,984 ▲ 13% vs 2022 (€ 167,093) Unfavourable step	€ 218,115 Total debts 2024: € 218,115 ▲ 15% vs 2023 (€ 188,984) Unfavourable step	▲ 15%
Cash	€ 43,249 Cash 2021: € 43,249 First fiscal year in the series	€ 54,756 Cash 2022: € 54,756 ▲ 27% vs 2021 (€ 43,249) Favourable step	€ 36,757 Cash 2023: € 36,757 ▼ 33% vs 2022 (€ 54,756) Unfavourable step	€ 58,865 Cash 2024: € 58,865 ▲ 60% vs 2023 (€ 36,757) Favourable step	▲ 60%
Land & buildings	€ 219,548 Land & buildings 2021: € 219,548 First fiscal year in the series	€ 199,944 Land & buildings 2022: € 199,944 ▼ 9% vs 2021 (€ 219,548) Unchanged	€ 184,618 Land & buildings 2023: € 184,618 ▼ 8% vs 2022 (€ 199,944) Unchanged	€ 161,145 Land & buildings 2024: € 161,145 ▼ 13% vs 2023 (€ 184,618) Unchanged	▼ 13%
Retained profit	€ 165,375 Retained profit 2021: € 165,375 First fiscal year in the series	€ 172,244 Retained profit 2022: € 172,244 ▲ 4% vs 2021 (€ 165,375) Favourable step	€ 125,240 Retained profit 2023: € 125,240 ▼ 27% vs 2022 (€ 172,244) Unfavourable step	€ 79,302 Retained profit 2024: € 79,302 ▼ 37% vs 2023 (€ 125,240) Unfavourable step	▼ 37%
Bank debt	€ 14,776 Bank debt 2021: € 14,776 First fiscal year in the series	€ 29,367 Bank debt 2022: € 29,367 ▲ 99% vs 2021 (€ 14,776) Unfavourable step	€ 43,019 Bank debt 2023: € 43,019 ▲ 46% vs 2022 (€ 29,367) Unfavourable step	€ 68,710 Bank debt 2024: € 68,710 ▲ 60% vs 2023 (€ 43,019) Unfavourable step	▲ 60%
Balance sheet total	€ 382,233 Balance sheet total 2021: € 382,233 First fiscal year in the series	€ 357,938 Balance sheet total 2022: € 357,938 ▼ 6% vs 2021 (€ 382,233) Unchanged	€ 332,824 Balance sheet total 2023: € 332,824 ▼ 7% vs 2022 (€ 357,938) Unchanged	€ 316,017 Balance sheet total 2024: € 316,017 ▼ 5% vs 2023 (€ 332,824) Unchanged	▼ 5%

Key figures of PHARMACIE CHAUSSEE DE GAND, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to PHARMACIE CHAUSSEE DE GAND?

What happened at PHARMACIE CHAUSSEE DE GAND in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 27, 2025 New annual accounts for financial year 2024: loss of € 45,938. filed late Source: NBB ↗
Oct 24, 2001 New establishment in Sint-Jans-Molenbeek. KBO
Jun 27, 2001 Start of the company according to the CBE. KBO

In short

From € 28,184 profit in 2021 to € 45,938 loss in 2024.

Paid € 13,691 in corporate taxes since 2021.

Best year ever: 2021, with € 28,184 profit.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMACIE CHAUSSEE DE GAND? We notify you, reason included.

Follow PHARMACIE CHAUSSEE DE GAND

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Establishments

Establishment units

Physical locations of this company

Registered office

Gentsesteenweg 120

1080 Sint-Jans-Molenbeek

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0475.089.865

VAT number

BE 0475.089.865

Registered office

Gentsesteenweg 120, 1080 Sint-Jans-Molenbeek

Names & denominations

PHARMACIE CHAUSSEE DE GAND

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

27 June 2001

Peppol

Active · Active since 15 Jul 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Detailhandel in cosmetica en toiletartikelen

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗